Rare dominant genes with high penetrance can be identified by linkage without inbreeding, whereas rare recessive genes with high penetrance are most efficiently recognized by autozygosity mapping of homozygotes in pedigrees with preferential inbreeding. On the contrary, complex inheritance is characterized by common genes with low penetrance, for which family studies and inbreeding are inefficient. Here, we develop the Fisherian theory for diallelic cases and controls, show that it compares favorably with Bayesian estimates, and evaluate their currently low power for discriminating cases and controls in Crohn disease (CD). Significance is enhanced by inclusion of composite likelihood, but identification of causal loci is delayed by low recognition of gene function. Clearly, association mapping is not yet optimal, and so strenuous effort is justified to develop a more inclusive gene map and association tests more powerful than single markers and the current use of composite likelihood. Because of its relatively high heritability and the correspondingly large number of detected causal loci, CD presents an ideal test system to determine the power and flaws of competing methods of whole-genome case/ control association analysis in publicly available data. Until such a test is exploited by competing statisticians, their Herculean efforts will be inconclusive, and the costly advances from increased sample size will be suboptimal and disappointing. association mapping ͉ composite likelihood ͉ method comparison
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association mapping ͉ composite likelihood ͉ method comparison G enome scans of diallelic cases and controls usually reduce genotypes to 2 ϫ 2 allele counts that in a population near panmixia conform closely to large-sample theory for testing the null hypothesis of no association. Once that hypothesis is in doubt, the 3 ϫ 2 genotypic distribution becomes competitive in power and more informative about expression. So far, the potential of association to reveal genetic heterogeneity has not been exploited, because analysis before the HapMap Project depended on relationship rather than gene frequency (1) and on linkage instead of association (2, 3) . At this early stage of analysis, two problems must be addressed. First, relative risks and their genotypic expectations are required for models of diallelic interaction. Secondly, information from multiple markers must be efficiently combined and augmented by composite likelihood and other methods. Ultimately, the combinations in genome-wide association (GWA) may be factored into causal subsets. Rigorous tests at all levels are essential if association mapping is to realize its promise for genetic counseling and genotype-specific treatment (4). Here, we develop the theory and apply it to Crohn disease (CD), one of seven illnesses studied by the Wellcome Trust Case Control Consortium (WTCCC) (5) ''with a view to exploring the utility, design, and analysis of GWA studies.'' Their anonymized data have been generously provided to other researchers as a further ''step toward harnessing the powerful molecular genomic tools now available to dissect the biological basis of common disease.'' Results Most Significant SNPs. In response to this stimulus, many methods to increase the power of association mapping are being explored. Nearly all incorporate the most significant diallelic singlenucleotide polymorphisms (msSNPs) in a defined region or regions. The WTCCC report gave megabase (Mb) locations for 112 msSNPs considered to be most significant. Data on four imputed markers and two unidentified markers were not available, and evidence on two SNPs associated with the X chromosome or sex-specific expression were incomplete, leaving 104 msSNPs common to both samples. Bayesian analysis (5) requires assumptions about prior probabilities that are not involved in Fisherian analysis, which uses first derivatives of log-likelihood to obtain point estimates, standard errors, and tests of goodness of fit by Newton-Raphson iteration [see supporting information (SI) Table S1 ]. Despite differences among models and between Bayesian and Fisherian approaches, agreement among six estimates of 2 2 was remarkably close (Table 1) . We therefore accepted the unweighted mean to identify the most significant SNPs (Table 2) .
In this tail of the msSNP distribution, the impact of 2 2 ϭ Α 1 2 for testing Hardy-Weinberg equilibrium independently in cases and controls has no striking effect, but large values depress weaker evidence of msSNP significance (Table S2 ). The 18 most significant msSNPs include all proven genes for CD at the time of the WTCCC report. Their mean 2 2 values exceed 23.03 and correspond to P Ͻ 10 Ϫ5 , predicting Ϸ469397 P ϭ 5 type I errors. Excluding two SNPs drawn from the same locus as another SNP, there are six confirmed loci, four suggested loci, and six SNPs assigned to multilocus regions. Evidence on other msSNPs is currently inconclusive, although an msSNP on the X chromosome (rs2807261) and a sex-specific SNP on chromosome 2 (rs3792048) have been suggested (5) . Undoubtedly, a few type I errors (falsely claiming disease risk) remain to be discarded, and an unpredictable number of type II errors (failure to detect a true risk) remain to be corrected. Their resolution is delicate because a large region may have both types of error.
Assessment of Disease Risk. We applied the ␤ model for additivity on the logistic scale (Table 3) to all cases and controls to evaluate risk predicted through msSNPs (Table 4 ). NOD2 and IRGM each had two msSNPs, from which we discarded rs17221417 and rs1147270 with lesser 2 2 and greater Hardy-Weinberg deviation, reducing the number of effective msSNPs to 16. In the first analysis, the scores for each individual were summed, and the distribution among individuals within case/control categories was examined. There is considerable overlap between categories (Table 5 ), but the difference is enormously significant. Pooling the values above and below zero into a 2 ϫ 2 table, 1 2 ϭ 282. The mean score without pooling is Ϫ0.23164 for controls and 0.23705 for cases, with corresponding standard errors 0.012590 and 0.017105, giving 1 2 ϭ 487. Even if the sample size and number of SNPs is substantially increased, this will be insufficient to overcome the limitation of association mapping based only on msSNPs to discriminate between cases and controls and thereby determine disease risk for genetic counseling and genotypespecific treatment.
Composite Likelihood and Combined Tests. These refinements offer one way to increase the power of msSNPs. If the most significant (ms) SNP in the region has 2ms 2 and composite likelihood (cl) contributes 2cl 2 , let y ϭ 2ms 2 , x ϭ 2cl 2 , and assume y ϭ kx ϩ , where k reflects the number of SNPs per region, and is random error with zero expectation. Following convention, we entertained three models for estimates of k from the 104 most significant observations: (i) constant variance, k ϭ ¥xy/¥x 2 ; (ii) standard deviation of y proportional to x, k ϭ ¥(y/x)/n; and (iii) variance of y proportional to x, k ϭ ¥y/¥x. Given the chosen model, the correlated values were combined as the mean, 2 2 ϭ ( 2ms
2 )/2. The estimate of k was 1.40 for model 1, 6.01 for model 2, and 1.93 for model 3. The latter was adopted, being intermediate and the most plausible (variance of y proportional to x). The 18 most significant msSNPs that were identified in Table 2 give high values of 2 2 for composite likelihood, suggesting adequate compensation for the difference among 1,000 replicates and the optimal value of 10,000 or more if P Յ 10 Ϫ4 as studied by Zhang in Gibson et al. (6) . 2 2 for composite likelihood falls off more rapidly as the evidence from msSNPs diminishes, reflecting significant departures from Hardy-Weinberg proportions, two or more peaks and/or low SNP density in composite likelihood, and constraints of sample size and gene frequency. We therefore assigned to Table S3 the lower half of 2 2 that contains no known causal SNPs and concentrated on the upper half (Table 6) , where known causal loci were clustered among the most significant ranks. However, we identified no novel loci. The causes appear complex, as considered below.
Discussion
Studies of CD in monozygous twins support a heritability of .50, but the sample of twins reared apart is too scanty to exclude environmental confounding (7) . Rare dominant genes with high penetrance are seldom found and are often costly, of low power, and effective localization through pedigrees is not encouraged by ethics committees. Rare recessive genes have these constraints, and a choice must be made between large and accessible populations with low inbreeding and smaller or inaccessible populations with high inbreeding. There is little evidence of inbreeding effects, and therefore a model of multiple loci with intermediate allele frequencies is currently favored, replacing family studies of haplotypes by whole-genome scans of single SNPs and composite likelihood. High SNP density and large samples are required for high power. Modest initial success is often followed by less spectacular results, leading to more ambitious studies that may include regional sequencing of insertions, deletions, polymorphic RNA, and other variants outside familiar SNPs.
It is too early to assess the cost and gain of recent developments, but two problems are persistent. First, as the density of tested SNPs increases, the length of a region containing a single msSNP tends to decrease. If this is incorrectly modeled, composite likelihood may be seriously distorted, locating the maximum outside the correct confidence interval and creating invalid information estimates that may be negative for variances and zero or otherwise misleading for covariances. Identification of a region compatible with a single causal SNP may provide insufficient markers for reliable composite likelihood, and complex models involving multiple causal SNPs have not yet proven to be superior. A second problem is that the inverse Hessian matrix should never have a negative value along the principal diagonal. This condition was initially violated for CD-KAL1, the weakest locus assignment in Table 6 but supported by other evidence (8) . The low density of typed markers near the msSNP may have caused this problem, which was not encountered for any other region. However, a more sophisticated algorithm might increase power and reduce error in point estimation. This was observed in an earlier study that estimated the Malecot parameters L and M at values of the LD location S around the single msSNP, without estimating the error variance under H 0 (9), a refinement that has not yet been implemented for genome-wide association at high density. Three kinds of evidence (schematic, genetic, and statistical) support the complexity of association mapping. The first class includes studies that pool CD with ulcerative colitis (UC), a more common variant of inflammatory bowel disease (IBD). Exceptionally, coeliac disease, unfortunately with the same abbreviation but a different etiology, is pooled with the rarer CD. Such lumping (wisely avoided in the WTCCC study) perpetuates error in discriminating cases and controls, frustrating identification of causal subsets and spoiling their promise for counseling and genotypespecific treatment. Strong genetic evidence is illustrated by a 5p31.1 CD locus within a 1.25 Mb gene desert (10) . The locus modulates expression of PTGER4, presumably cis-acting. At the opposite extreme, increasingly elaborate statistical models have been developed with the goal of increasing power without requiring collection of additional samples. The most recent and ambitious model includes evidence from msSNPs, linkage disequilibrium (LDU), and Hardy-Weinberg disequilibrium, with estimates of pairwise covariates producing mutually independent statistics (11). Heavy calculations of many alterations are anticipated, with power, reliability, and computation time to be determined.
Despite these difficulties, Table 6 shows that many of the combined association tests provide stronger evidence than the regional msSNP to identify causal regions, whether or not a causal locus has been identified. In many cases, the location estimated from composite likelihood agrees closely with the msSNP in that region, and so we attribute the low identification of causal loci within highly significant regions to low recognition of gene function. Single SNPs do not represent genome diversity, and identification of causal regions is still primitive. More causal genes, causal markers within those genes, and their interactions will be required for elucidation of diseases with a significant genetic origin. Clearly association is not yet optimal, and so the current effort to develop more comprehensive maps and more powerful mapping methods than single msSNPs is clearly justified.
A strong argument can be made that the current plethora of association methods with few tests demand an objective evaluation by whole-genome case/control analysis of publicly available data with a large number of detected causal loci and reasonable anticipation of others that could be detected by a more powerful test. The WTCCC sample for CD produces an ideal test system to determine the power and flaws of competing methods. A statistician advocating a method without testing in this way loses credibility, and a geneticist advocating suboptimal methods on ever-increasing samples loses support.
Materials and Methods
The experimental design for CD aimed to distinguish it from UC and other forms of IBD that share some but not all causal genotypes. The design provided 2,000 cases and 3,000 controls with an Affymetrix chip comprising 500,568 SNPs. We did our best to follow the criteria used by WTCCC to exclude samples for contamination, false identity, non-Caucasian ancestry, and relatedness and to reject SNPs that did not pass their quality control filters. This left 1,748 cases in agreement with their Table S1 , 2,938 controls, and 469,397 SNPs, of which 112 were classified as having a nominal P value Ͻ10 Ϫ4 by at least one of two methods, in agreement with ref. 5.
Model Definition. Following Collins et al. (12)
, we consider four classes of model, the relative risks of which are arranged so that GG designates the highest risk (S1). The simplest model (␣) assumes equal risk for cases (n) and controls (N) and for the three genotypes. If necessary to conform with the risk constraint that ␤, ␥, and ⌬ not be negative, the condition that (2n22 ϩ n12)/2n Ն (2N 22 ϩ N12)/2N is imposed by interchanging n11 with n22 and N11 with N22 without changing symbol order. Following convention, we consider cases and controls separately, relying on subsequent analysis to control possible effects of sample enrichment, so far not demonstrated. On the null hypothesis of Hardy-Weinberg equilibrium and equal risk in cases and controls, the only parameter to be estimated is frequency p for the g allele with q ϭ 1 Ϫ p for the G allele and information K p ϭ 2(n ϩ N)/p(1 Ϫ p). Denoting observed frequencies by 0 1 to 06 and their expected frequencies by 1 to 6, the Pearson 3 2 equals
and the corresponding likelihood ratio 3 2 is
with 0i(ln 0i) ϭ zero. Other models are associated with the G allele, which is, by definition, more frequent in cases than controls, and therefore with a smaller value of p. Table 4 . Scores for best model as ln (P1/P0) for a given genotype
For the ␤ model, penetrance is additive on the logistic scale. In this and subsequent models, two cumbersome expressions that are repeated several times are denoted by x for lnL and y for U p. Estimation of p and ␤ leaves two degrees of freedom (df) to test logistic additivity and other assumptions of the model. The ␥ model assumes additivity on the penetrance scale, also leaving 2 df to test the model. They are absent in the more familiar 2 ϫ 2 table of allele ϫ case/control, which gives similar estimates of p and ␥. In the unlikely event that any of the observations a, b, c, or d is zero, each of the four possible observations may be augmented by 0.5 in estimating ␥ and by 1 in computing its variance (13) . The most complete model we have examined has parameters (Table 6 ). Then 1 2 ϭ 2¥ ln(P1j/P0j) tests significance for the jth individual and z ϭ 1 2 /(2 ln 10) is the corresponding logarithm of odds score familiar in linkage analysis (15) . Risk in controls depends on age-related incidence in the population and success of risk detection and exclusion. Risk detection depends now on conventional diagnosis, but association analysis will become increasingly important as causal markers are identified, and their scoring becomes more efficient, enhancing the value of these calculations in a given set of individuals.
Composite Likelihood. Although msSNPs have proven their utility, significance is usually limited to the small proportion of SNPs with minor allele frequencies Ͼ0.05, and information from msSNPs is not combined. Many complementary strategies have been advocated, and some have been applied. One of these is composite likelihood, which combines information from multiple markers and can exploit maps in linkage disequilibrium units (LDU) that reflect highresolution recombination. Whereas inclusion of a causal SNP favors msSNPs, omission can be compensated by multiple SNPs in a region of significant linkage disequilibrium. Previous experience has been with whole-genome scanning (6), but here, we examine regions around most significant SNPs, placing each candidate near the center of at least 30 SNPs and 10 LDU. Conventional analysis provides a location confidence interval in LDU and interpolation to the physical map in base pairs (16) . Nominal values for composite likelihood must allow for underestimate of 2 2 when the number of replicates under H 0 falls far short of the 10/p standard required for a reliable estimate (6) . Because this is unavoidable when 2 2 is large, we allowed no more than 1,000 replicates and used an empirical estimate to express the relationship between 2 2 for an msSNP and composite likelihood.
